Ladenburg Thalmann Financial Services’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $576K | Sell |
10,658
-436
| -4% | -$23.6K | ﹤0.01% | 1691 |
|
|
2019
Q3 | $580K | Sell |
11,094
-261
| -2% | -$13.6K | ﹤0.01% | 1642 |
|
|
2019
Q2 | $528K | Sell |
11,355
-372
| -3% | -$17.3K | ﹤0.01% | 1701 |
|
|
2019
Q1 | $592K | Buy |
11,727
+760
| +7% | +$38.4K | ﹤0.01% | 1574 |
|
|
2018
Q4 | $650K | Sell |
10,967
-1,409
| -11% | -$83.5K | 0.01% | 1347 |
|
|
2018
Q3 | $814K | Sell |
12,376
-1,200
| -9% | -$78.9K | 0.01% | 1258 |
|
|
2018
Q2 | $715K | Hold |
13,576
| – | – | 0.01% | 1280 |
|
|
2018
Q1 | $715K | Buy |
13,576
+952
| +8% | +$50.1K | 0.01% | 1280 |
|
|
2017
Q4 | $587K | Buy |
12,624
+50
| +0.4% | +$2.33K | 0.01% | 1438 |
|
|
2017
Q3 | $509K | Buy |
12,574
+1,062
| +9% | +$43K | 0.01% | 1457 |
|
|
2017
Q2 | $390K | Buy |
11,512
+10,412
| +947% | +$353K | ﹤0.01% | 1546 |
|
|
2017
Q1 | $32K | Buy |
1,100
+950
| +633% | +$27.6K | ﹤0.01% | 3233 |
|
|
2016
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 4209 |
|
|
2016
Q3 | $5K | Sell |
150
-905
| -86% | -$30.2K | ﹤0.01% | 4139 |
|
|
2016
Q2 | $30K | Buy |
1,055
+371
| +54% | +$10.6K | ﹤0.01% | 3057 |
|
|
2016
Q1 | $25K | Buy |
684
+116
| +20% | +$4.24K | ﹤0.01% | 3090 |
|
|
2015
Q4 | $23K | Buy |
568
+204
| +56% | +$8.26K | ﹤0.01% | 3114 |
|
|
2015
Q3 | $10K | Buy |
364
+89
| +32% | +$2.45K | ﹤0.01% | 3526 |
|
|
2015
Q2 | $9K | Buy |
275
+135
| +96% | +$4.42K | ﹤0.01% | 3735 |
|
|
2015
Q1 | $4K | Buy |
140
+94
| +204% | +$2.69K | ﹤0.01% | 4056 |
|
|
2014
Q4 | $1K | Buy |
+46
| New | +$1K | ﹤0.01% | 4192 |
|